CytoSorbents to Present at the HC Wainwright 26th Annual Global Investment Conference Page 1

PRINCETON, NJ, August 27, 2024 (GLOBE NEWSWIRE) — CytoSorbents Corporation (NASDAQ: CTSO), a leader in treating life-threatening conditions in intensive care and cardiac surgery using blood purification via its proprietary polymer adsorption technology, today announced that Dr. Phillip Chan, Chief Executive Officer, and Peter J. Mariani, Chief Financial Officer, will be presenting at the HC Wainwright 26^and Annual Global Investment Conference will take place September 9-11, 2024 at the Lotte New York Palace Hotel in New York, NY.

A company presentation is available upon request here beginning Monday, September 9 at 7:00 a.m. ET. CytoSorbents’ management team will be available for one-on-one meetings on Monday, September 9, 2024. Interested investors should contact their HC Wainwright representative. A replay of the presentation, when available, will be posted on CytoSorbents’ website at Events & Presentation investor section page for 90 days.